Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.35061 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.30676 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.31263 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.18504 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.21329 | 52 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.4661 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.42323 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.29033 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.29549 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.29448 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.30071 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.28224 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.32898 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.30357 | 53 |